Skip to content

Orphan Drugs: EMA’s COMP May 2013 Meeting Results

May 25, 2013

EMA’s Committee for Orphan Medicinal Products (COMP) held a meeting May 14 – 15, 2013. The EMA COMP May 2013 Meeting Report on the review of applications for orphan designation is published May 24, 2013. At this meeting, there are 10 positive opinions recommending orphan designation for the treatment of :

  1. Cystic Fibrosis
  2. Retinitis Pigmentosa (3 products)
  3. Squamous Cell Carcinoma of Head & Neck
  4. Soft Tissue Sarcoma
  5. Acute Liver Failure
  6. Mucopolysaccharidosis Type IIIB (Sanfilippo B Syndrome)
  7. Amyotrophic Lateral Sclerosis (ALS)
  8. Pachyonychia Congenita.

2013 EMA COMP Calendar

  1. June 11 – 12, 2013
  2. July 9 – 10, 2013
  3. September 3 – 4, 2013
  4. October 8 – 9, 2013
  5. November 5 – 6, 2013
  6. December 10 – 11, 2013.

Please Note: “Purple Check” by Rocket000 [Public domain] | Wikimedia Commons.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: